Загрузка...
New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia
Although imatinib revolutionized the management of chronic myeloid leukemia (CML), recent data indicate a transformation in the treatment approach likely in the near future. The superiority of second-generation tyrosine kinase inhibitors (TKIs) over imatinib in newly diagnosed disease has been recog...
Сохранить в:
| Опубликовано в: : | Leuk Lymphoma |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5681224/ https://ncbi.nlm.nih.gov/pubmed/21299461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.546917 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|